NDC product
Ivarest
NDC 10157-9077 · Blistex Inc
Key facts
| Product NDC | 10157-9077 |
|---|---|
| Proprietary name | Ivarest |
| Nonproprietary name | Zinc Oxide, Benzyl Alcohol, and Diphenhydramine Hydrochloride |
| Substances | ZINC OXIDE, BENZYL ALCOHOL, DIPHENHYDRAMINE HYDROCHLORIDE |
| Dosage form | CREAM |
| Route | TOPICAL |
| Labeler | Blistex Inc |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M016 |
| Pharmacologic classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Pediculicide [EPC] |
| Marketing start | Dec 31, 2007 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: